Lymphoma

LYMPHOMA ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Eponyms in Oncology: Bence-Jones Protein

This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of the Bence-Jones protein.
Most Blood Cancer Drug Trials Are Not Randomized, Use Surrogate Endpoints

Of more than 2500 trials analyzed, 21% were randomized.
Eponyms in Oncology: Waldenström Macroglobulinemia

This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of Waldenström macroglobulinemia.
Eponyms in Oncology: Virchow’s Node

This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of Virchow’s node.
Phthalates in Medications May Increase Risk of Childhood Cancers

Children prescribed a medication containing a phthalate had a 19% higher risk of developing any childhood cancer.

LYMPHOMA NEWS

DLBCL

Tisagenlecleucel Plus Pembrolizumab May Be Effective in R/R DLBCL

September 27, 2022

DLBCL

Orelabrutinib Plus R-CHOP Appears Active in Extranodal, Non-GCB DLBCL

September 22, 2022

A depiction of a genome.

Genomic Features and Anti-CD19 CAR-T Therapy Failure in Large B-Cell Lymphoma

September 21, 2022

Micrograph of cutaneous T-cell lymphoma

Cutaneous T-Cell Lymphoma Incidence on the Rise in the United States

September 15, 2022

Triplet Falls Short in Relapsed/Refractory Chronic Lymphocytic Leukemia

September 14, 2022

Next post in Lymphoma

A depiction of a genome.

Genomic Features and Anti-CD19 CAR-T Therapy Failure in Large B-Cell Lymphoma